Amphiphilic interpenetrating networks for the delivery of hydrophobic, low molecular weight therapeutic agents

Industrial and Engineering Chemistry Research

Volumn 50, Issue 22, 2011, Pages 12556-12561

  Schoener, Cody A ^a   Hutson, Heather N ^a   Fletcher, Grace K ^a   Peppas, Nicholas A ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHILICS; DYNAMIC SWELLING; EQUILIBRIUM SWELLING; LOADING EFFICIENCY; LOW MOLECULAR WEIGHT; LOW MOLECULAR WEIGHT DRUGS; METHACRYLIC ACIDS; NEUTRAL PH; PH-RESPONSIVE HYDROGELS; POLY(N-BUTYL ACRYLATE); RELEASE PROFILES; SMALL INTESTINE; SWELLING BEHAVIOR; SWELLING RATIO; THERAPEUTIC AGENTS; TRIGGERED RELEASE;

ETHYLENE; GLYCOLS; HYDROGELS; HYDROPHILICITY; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; SWELLING;

HYDROPHOBICITY;

EID: 80855144303     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/ie201593h     Document Type: Article

References (41)

1. Peppas, N. A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical formulations Eur. J. Pharm. Biopharm. 2000, 50, 27-46 (Pubitemid 30326687)
2. Blanchette, J.; Kavimandan, N.; Peppas, N. A. Principles of transmucosal delivery of therapeutic agents Biomed. Pharmacother. 2004, 58, 142-151 (Pubitemid 38479918)
3. Mao, J. H.; Balmain, A. Genomic approaches to identification of tumour-susceptibility genes using mouse models Curr. Opin. Genet. Dev. 2003, 13, 14-19 (Pubitemid 36143922)
4. Ohmori, K.; Sasaki, K.; Asada, S.; Tanaka, N.; Umeda, M. An assay method for the prediction of tumor promoting potential of chemicals by the use of Bhas 42 cells Mutat. Res., Genet. Toxicol. Environ. Mutagen. 2004, 557, 191-202 (Pubitemid 38068559)
5. Schrenk, D.; Schmitz, H. J.; Bohnenberger, S.; Wagner, B.; Worner, W. Tumor promoters as inhibitors of apoptosis in rat hepatocytes Toxicol. Lett. 2004, 149, 43-50 (Pubitemid 38469819)
6. Wolfle, D. Enhancement of carcinogen-induced malignant cell transformation by prostaglandin F-2 alpha Toxicology 2003, 188, 139-147 (Pubitemid 36588896)
7. Van Cutsem, E.; Twelves, C.; Cassidy, J.; Allman, D.; Bajetta, E.; Boyer, M.; Bugat, R.; Findlay, M.; Frings, S.; Jahn, M.; McKendrick, J.; Osterwalder, B.; Perez-Manga, G.; Rosso, R.; Rougier, P.; Schmiegel, W. H.; Seitz, J. F.; Thompson, P.; Vieitez, J. M.; Weitzel, C.; Harper, P. Xeloda Colorectal Canc Study, G.: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study J. Clin. Oncol. 2001, 19, 4097-4106 (Pubitemid 33049527)
8. Boeck, S.; Wilkowski, R.; Bruns, C. J.; Issels, R. D.; Schulz, C.; Moosmann, N.; Laessig, D.; Haas, M.; Golf, A.; Heinemann, V. Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer Oncology 2007, 73, 221-227 (Pubitemid 351630054)
9. Beach, D. F.; Somer, R. Novel approach to Gorlin Syndrome: A patient treated with oral capecitabine J. Clin. Oncol. 2011, 29, E397-E401
10. Miwa, M.; Ura, M.; Nishida, M.; Sawada, N.; Ishikawa, T.; Mori, K.; Shimma, N.; Umeda, I.; Ishitsuka, H. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur. J. Cancer 1998, 34, 1274-1281 (Pubitemid 28342121)
11. Irshad, S.; Maisey, N. Considerations when choosing oral chemotherapy: identifying and responding to patient need Eur. J. Cancer Care 2010, 19, 5-11
12. Liu, G.; Franssen, E.; Fitch, M. I.; Warner, E. Patient preferences for oral versus intravenous palliative chemotherapy J. Clin. Oncol. 1997, 15, 110-115 (Pubitemid 27021524)
13. Zhang, J.; Peppas, N. A. Synthesis and characterization of pH- and temperature-sensitive poly(methacrylic acid)/poly(N -isopropylacrylamide) interpenetrating polymeric networks Macromolecules 2000, 33, 102-107 (Pubitemid 32212698)
14. Liu, Y. Y.; Shao, Y. H.; Lu, J. Preparation, properties and controlled release behaviors of pH-induced thermosensitive amphiphilic gels Biomaterials 2006, 27, 4016-4024 (Pubitemid 44316594)
15. Shin, Y. C.; Han, D. K.; Kim, Y. H.; Kim, S. C. Antithrombogenicity of hydrophilic polyurethane-hydrohobic polystyrene IPNs. 2. In-vitro and ex-vivo studies J. Biomater. Sci., Polym. Ed. 1994, 6, 281-295
16. Mohan, N.; Nair, P. D. Polyvinyl alcohol-poly(caprolactone) semi IPN scaffold with implication for cartilage tissue engineering J. Biomed. Mater. Res., Part B 2008, 84B, 584-594
17. Lowman, A. M.; Peppas, N. A. Molecular analysis of interpolymer complexation in graft copolymer networks Polymer 2000, 41, 73-80 (Pubitemid 29506997)
18. Lopez, J. E.; Peppas, N. A. Effect of poly(ethylene glycol) molecular weight and microparticle size on oral insulin delivery from P(MAA- g -EG) microparticles Drug Dev. Ind. Pharm. 2004, 30, 497-504 (Pubitemid 38821861)
19. Kim, B.; Peppas, N. A. Analysis of molecular interactions in poly(methacrylic acid-g-ethylene glycol) hydrogels Polymer 2003, 44, 3701-3707 (Pubitemid 36648643)
20. Madsen, F.; Peppas, N. A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition Biomaterials 1999, 20, 1701-1708 (Pubitemid 29393125)
21. Thomas, J. B.; Tingsanchali, J. H.; Rosales, A. M.; Creecy, C. M.; McGinity, J. W.; Peppas, N. A. Dynamics of poly(ethylene glycol)-tethered, pH responsive networks Polymer 2007, 48, 5042-5048 (Pubitemid 47176047)
22. Lowman, A. M.; Morishita, M.; Kajita, M.; Nagai, T.; Peppas, N. A. Oral delivery of insulin using pH-responsive complexation gels J. Pharm. Sci. 1999, 88, 933-937 (Pubitemid 29438959)
23. Nakamura, K.; Murray, R. J.; Joseph, J. I.; Peppas, N. A.; Morishita, M.; Lowman, A. M. Oral insulin delivery using P(MAA- g -EG) hydrogels: effects of network morphology on insulin delivery characteristics J. Controlled Release 2004, 95, 589-599 (Pubitemid 38340508)
24. Kavimandan, N. J.; Losi, E.; Peppas, N. A. Novel delivery system based on complexation hydrogels as delivery vehicles for insulin-transferrin conjugates Biomaterials 2006, 27, 3846-3854
25. Carr, D. A.; Gomez-Burgaz, M.; Boudes, M. C.; Peppas, N. A. Complexation hydrogels for the oral delivery of growth hormone and salmon calcitonin Ind. Eng. Chem. Res. 2010, 49, 11991-11995
26. Torres-Lugo, M.; Peppas, N. A. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin Macromolecules 1999, 32, 6646-6651
27. Morishita, M.; Kamei, N.; Chiba, H.; Kavimandan, N. J.; Peppas, N. A.; Takayama, K. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin J. Controlled Release 2009, 134, 98-102
28. Blanchette, J.; Peppas, N. A. Oral chemotherapeutic delivery: Design and cellular response Ann. Biomed. Eng. 2005, 33, 142-149 (Pubitemid 40496044)
29. Blanchette, J.; Park, K.; Peppas, N. A. Use of complexation hydrogels for oral administration of chemotherapeutic agents Trans. Soc. Biomater. 2003, 89, 1606-1613
30. Liechty, W. B.; Caldorera-Moore, M.; Phillips, M. A.; Schoener, C.; Peppas, N. A. Advanced molecular design of biopolymers for transmucosal and intracellular delivery of chemotherapeutic agents and biological therapeutics. J. Controlled Release 2011, in press.
31. Hou, Y.; Schoener, C. A.; Regan, K. R.; Munoz-Pinto, D.; Hahn, M. S.; Grunlan, M. A. Photo-cross-linked PDMSstar-PEG hydrogels: synthesis, characterization, and potential application for tissue engineering scaffolds Biomacromolecules 2010, 11, 648-656
32. Munoz-Pinto, D. Hybrid polyethylene glycol hydrogels for tissue engineering applications. Ph.D. Dissertation, Texas A&M University, College Station, TX, 2011.
33. Zhang, J.; Qian, Z. Y.; Gu, Y. Q. In vivo anti-tumor efficacy of docetaxel-loaded thermally responsive nanohydrogel Nanotechnology 2009, 20, 1-8
34. Patel, R. B.; Carlson, A. N.; Solorio, L.; Exner, A. A. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems J. Biomed. Mater. Res., Part A 2010, 94A, 476-484
35. Reddy, S. M.; Sinha, V. R.; Reddy, D. S. Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs Drugs Today 1999, 35, 537-580 (Pubitemid 29422129)
36. Blanchette, J.; Peppas, N. A. Cellular evaluation of oral chemotherapy carriers J. Biomed. Mater. Res., Part A 2005, 72A, 381-388 (Pubitemid 40315852)
37. Peppas, N. A.; Wood, K. M.; Blanchette, J. O. Hydrogels for oral delivery of therapeutic proteins Expert Opin. Biol. Ther. 2004, 4, 881-887 (Pubitemid 38843225)
38. Wood, K. M.; Stone, G. M.; Peppas, N. A. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery Biomacromolecules 2008, 9, 1293-1298 (Pubitemid 351639584)
39. Phillips, M. R.; Peppas, N. A. Hydrogels modified with carbohydrates for oral protein delivery Trans. Ann. Biomater. Meet. 2009, 33, 267
40. Krishnaiah, Y. S. R.; Satyanarayana, V.; Kumar, B. D.; Karthikeyan, R. S.; Bhaskar, P. In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets Eur. J. Pharm. Sci. 2003, 19, 355-362 (Pubitemid 36952397)
41. Liu, R.; Li, D.; He, B.; Xu, X.; Sheng, M.; Lai, Y.; Wang, G.; Gu, Z. Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(l -histidine-)-poly(l -lactide) nanoparticles J. Controlled Release 2011, 152, 49-56